DR. CARLOS RODRIGUEZ-GALINDO, MD

Plain English
This study looked at children diagnosed with retinoblastoma, a type of eye cancer, who were 5 years old or older. Out of 529 patients, only 25 (about 4.7%) were diagnosed at this later age, with most (96%) having the disease in just one eye. The researchers found that a significant number were misdiagnosed beforehand and also discovered genetic mutations in some patients, which may affect future treatment and outcomes. Who this helps: This information benefits doctors and families of children diagnosed with retinoblastoma, especially those identified later in life.

Plain English
This study looked at how quickly doctors can diagnose childhood cancer in Peru after a new national strategy was put in place in 2019. It found that the average time to diagnosis dropped from 107 days to 57 days, with half of the diagnoses made in just 26 days. This is important because faster diagnoses can lead to earlier treatment, which improves chances of survival for children with cancer. Who this helps: This benefits patients and their families by providing quicker access to necessary care.

Plain English
The study looked at clinical trials for children and teens with cancer in Latin America and found 47 trials in total. Most of these trials (88.8%) were sponsored by local institutions, but over half focused on supportive care instead of direct cancer treatments. Only 27.6% of the trials had published their results, highlighting a need for better research support in the region. Who this helps: This helps children and teenagers with cancer, as well as their healthcare providers.

Plain English
The 2025 Pediatric Oncology East and Mediterranean Conference brought together 351 delegates from 24 countries to share the latest in childhood cancer care. Key findings included the first regional results showing how car T-cell therapy is working in middle-income areas, improved survival rates for acute lymphoblastic leukemia, and advancements in bone marrow transplants. This is important because it helps improve treatment options and survival rates for children with cancer, especially in underserved regions. Who this helps: Patients with childhood cancer and their families.

Plain English
This study explored how doctors decide on treatments for children with advanced cancer in low- and middle-income countries, where resources are limited. Researchers interviewed 36 doctors and found that they typically recommend one of four treatment approaches. The decisions often depend on local resources and the families' preferences, with a total of seven potential outcomes based on how families respond to treatment ideas. Who this helps: This helps doctors and families of children with cancer in low- and middle-income countries.

Plain English
This study looked at clinical trials for children and teens with cancer around the world, focusing on the differences between high-income and low- or middle-income countries. Out of nearly 139,000 oncology trials, only about 3,149 were specifically for pediatrics, with 81.2% coming from high-income countries. This shows that low- and middle-income countries have fewer advanced treatment trials, which shows a need to improve access and collaboration for better care in these regions. Who this helps: This helps patients in low- and middle-income countries by highlighting the need for better access to cancer clinical trials.

Plain English
This study looked at a pediatric hematology/oncology fellowship program in Guatemala to see how it improved after receiving international accreditation. Before accreditation, the program scored 77.2%, which rose to 88.3% after changes were made, with big improvements in educational and evaluation aspects. This matters because a better training program means better care for children with cancer, which is crucial in a middle-income country like Guatemala. Who this helps: This helps patients and their families, as well as doctors training to provide better cancer care for children.

Plain English
This study looked at 67 eyes of retinoblastoma survivors who received chemotherapy directly in or around the eye from 2005 to 2020. It found that 79.1% of cases led to orbital fibrosis, which is a buildup of scar-like tissue, and cataracts were seen in 19.4% of eyes, with most of those needing surgery. These findings are important because they highlight the long-term problems that can arise after treatment, emphasizing the need for ongoing monitoring and care for these patients as their treatment guidelines change. Who this helps: This helps patients who have survived retinoblastoma and the doctors caring for them.

Plain English
This study looked at young cancer patients in Latin America and Spain who became critically ill while hospitalized and found that 26.8% (or 1,108 out of 4,134 critical events) resulted in death. Key factors that influenced these outcomes included patients experiencing disease relapse and those needing intensive care while on general wards. Identifying these factors is important because it highlights areas for targeted interventions that could improve survival rates for these vulnerable patients. Who this helps: This helps patients and healthcare providers working in pediatric cancer treatment.

Plain English
This study looked at how sharing tasks among different types of doctors can help deal with the shortage of pediatric oncologists in Pakistan, a low- and middle-income country. Researchers found that medical officers and pediatricians, referred to as task-sharing physicians (TSPs), play important roles in caring for young cancer patients. For example, they can help with diagnosing cancer, create chemotherapy plans, and perform procedures like lumbar punctures, with pediatric oncologists supervising their work. This approach is essential for ensuring that children with cancer receive adequate care despite the limited number of specialists. Who this helps: This helps pediatric cancer patients and their families by improving access to care.

Plain English
This study looked at how the ongoing conflict affected the diagnosis and treatment of children with cancer from Gaza who were treated in Jordan. Out of 51 children treated, 96% survived after four months, even though many faced long delays in getting care, such as waiting 3-4 months to be referred. Addressing these delays with better coordination of medical care is essential to ensure that children in conflict zones receive timely and life-saving treatment. Who this helps: This helps children with cancer in Gaza and other conflict-affected areas.

Plain English
This study focused on a 15-year-old girl diagnosed with a rare lung cancer called bronchial mucoepidermoid carcinoma (MEC) after experiencing cough, fever, and chest pain. Her diagnosis was complicated, but after thorough testing and a biopsy, doctors confirmed the cancer and treated her with chemotherapy and surgery. Remarkably, she has been in remission for five years without therapy, highlighting the importance of advanced testing and teamwork among specialists in making accurate diagnoses and improving patient outcomes. Who this helps: This helps patients with rare cancers and their healthcare providers.

Plain English
This study looked at a new online course designed to teach pediatric oncology to doctors in Zimbabwe and Zambia, where there are not enough specialists to provide proper training. Out of 25 participants, those who took the course showed significant improvement in their knowledge, as seen in a post-test score increase that was statistically meaningful (p = 0.0253). This is important because it helps doctors provide better care for children with cancer in areas that desperately need more education and resources. Who this helps: This helps doctors and healthcare providers working in pediatric oncology.

Plain English
The AMARTE Alliance is a network started in Brazil to improve cancer treatment for children by connecting hospitals and sharing resources. Since its launch, 31 hospitals have joined, with 17 improving their measurement scores for engagement. This collaboration has led to common standards for diagnosis and treatment, which is vital because it allows children across different regions to receive better, more uniform care regardless of where they live. Who this helps: This initiative benefits pediatric cancer patients and their families by providing more equitable access to quality treatment.

Plain English
This study looked at how well children with a specific type of cancer called intermediate-risk malignant germ cell tumors respond to chemotherapy. Out of 208 patients, 193 achieved complete remission after initial treatment, resulting in high survival rates of 93% for event-free survival and 99% for overall survival over four years. However, the 15 patients who did not achieve complete remission had much lower survival rates of 61% and 65% despite receiving extra chemotherapy, suggesting that continuing the same treatment may not be helpful. Who this helps: This research helps doctors make better decisions for children with this type of cancer, especially those who do not respond well to initial treatment.

Plain English
This study looked at how improvements in cancer treatment for children over the last 50 years have not been available to many patients worldwide. It found that by focusing on spreading and maintaining better healthcare practices, more children could receive high-quality care. These changes could help make cancer treatment more accessible and effective for all children, regardless of where they live. Who this helps: This helps children with cancer and their families.

Plain English
This study looked at how caregivers of children with cancer in Pakistan communicate and share information about their children's treatment. Researchers surveyed 200 caregivers and found that while over 90% recognized the importance of clear communication, many did not fully understand key aspects of their child's care, such as diagnosis and treatment duration—only 71% were clear about how long treatment would last. The findings highlight significant gaps in information exchange, emphasizing the need to improve communication practices so caregivers can better support their children through treatment. Who this helps: This helps caregivers, patients, and healthcare providers involved in pediatric cancer care.

Plain English
This study looked at how cultural factors influence caregivers' decision-making for children with cancer in Pakistan. Researchers surveyed 200 caregivers and found that 46.5% would share decision-making with other family members, while only 10% were the primary decision-makers, with 70% of those being male. Although many caregivers wanted to involve their children in discussions about their cancer, 70% reported that no one spoke to their child about it, highlighting the need to involve parents and respect cultural traditions in care decisions. Who this helps: This information benefits caregivers and healthcare providers in understanding how to better engage families in cancer treatment decisions.

Plain English
This study looked at how accessible a particular cancer treatment, CAR-T therapy for children with a type of leukemia, is across Europe. Researchers found that while CAR-T therapy is available in 71% of European countries, many lack the necessary clinical trials and collaborative networks, making equitable access a challenge. With an average of 60 new leukemia cases per country each year, the study highlights significant differences in treatment availability, urging improvements in healthcare infrastructure to better serve young patients. Who this helps: This benefits children with leukemia and their healthcare providers by improving access to essential treatments.

Plain English
This study aimed to improve how doctors classify and treat children with neuroblastoma, a type of cancer, especially in low- and middle-income countries where advanced resources are often not available. Researchers created a new classification system called Adaptive Clinical Neuroblastoma Risk Groups (ACNRG) using simple clinical markers, enabling them to identify 12 different risk groups with varying survival rates—ranging from 92% for the lowest risk to 28% for the highest risk over five years. This new system could lead to better treatment decisions and outcomes for children in these regions, where access to advanced testing is limited. Who this helps: Patients with neuroblastoma, especially those in low- and middle-income countries.

Plain English
This study focused on training pediatric neuro-oncologists in low and middle-income countries (LMICs) through a virtual fellowship program that included mentorship from global experts. Over two years, 11 fellows from 10 LMICs participated, resulting in significant improvements such as increased patient care, 33 presentations at medical conferences, and four published articles. This matters because it builds local expertise in treating children with brain tumors, ultimately leading to better healthcare outcomes in these regions. Who this helps: This helps pediatric cancer patients in low and middle-income countries.

Plain English
This research studied how combining chemotherapy and immunotherapy with reduced radiation can treat nasopharyngeal carcinoma in children and adolescents. By using a new approach that includes anti-PD-1 therapies, the goal is to keep survival rates high while minimizing the harmful side effects linked to radiation. This could help decrease long-term health issues for young survivors of this rare cancer. Who this helps: This helps patients, particularly children and adolescents with nasopharyngeal carcinoma.

Plain English
This research studied how implementing specific surgical guidelines affected treatment outcomes for children with hepatoblastoma, a type of liver cancer, between 2009 and 2018. Out of 226 children enrolled, 93% had surgery to remove tumors, and 65% of the surgeries followed the recommended timing guidelines. Following these guidelines led to better surgery rates without increasing complications, showing that consistent protocols can improve treatment for these young patients.

Plain English
The Pediatric Oncology East and Mediterranean (POEM) group studied a virtual forum set up for pediatric cancer professionals to discuss cases and share expertise from 2013 to 2021. They reviewed 140 cases from 14 countries and found that the biggest challenges were related to diagnosing cancer types (24%) and interpreting medical images (18%). The forum provided valuable recommendations for treatment, highlighted limitations in resources, and offered opportunities to improve cancer care across the region. Who this helps: This benefits pediatric cancer patients and their doctors.

Plain English
This study focused on understanding specific cells that come from rare disorders called histiocytoses, which occur when certain immune cells grow uncontrollably. Researchers examined these cells from three children with different types of histiocytoses and found that they have unique markers and behaviors. Importantly, the cells responded differently to two cancer drugs, vemurafenib and trametinib, highlighting their potential for testing new treatments. Who this helps: This research benefits doctors and researchers working on histiocytoses and related conditions.

Plain English
This study focused on Langerhans cell histiocytosis (LCH), a disease where the body produces too many certain immune cells that can cause various health issues, from mild to life-threatening. The authors found that fewer than 50% of patients with widespread disease are cured using the standard treatments, which can also lead to long-term health problems. They highlight new research showing that specific gene mutations, particularly BRAFV600E, play a key role in LCH, opening the door for more tailored and effective treatments. Who this helps: This research benefits patients with LCH by paving the way for more effective and personalized treatment options.

Plain English
This study looked at six young patients with advanced liver cancer to see how they responded to a new type of treatment called immunotherapy. Out of these six patients, three showed positive responses: one had a complete recovery, and the other two maintained stable disease for an extended period, while the remaining three patients worsened. The findings indicate that some children with this type of liver cancer could benefit from immunotherapy, emphasizing the need for further research to understand which patients are most likely to respond. Who this helps: This helps young patients with liver cancer and their doctors by identifying potential treatment options.

Plain English
The study focused on improving global access to cancer treatments by bringing together various stakeholders in the field, including doctors, researchers, and pharmaceutical companies. Meetings in 2022 and 2023 led to the recognition that better communication and cooperation between these groups are essential for making significant progress. Participants agreed on specific actions to tackle the barriers to accessing cancer medicines, helping to ensure that more patients can receive the care they need. Who this helps: This helps patients who need cancer treatments.

Plain English
The study focused on how Cure4Kids, an online resource for pediatric cancer education, was redesigned to better support healthcare professionals working with children facing cancer and other serious illnesses. The updated platform provides free online learning opportunities to meet the needs of these professionals. This transformation is important because it aims to reduce the global differences in survival rates for children with cancer. Who this helps: Healthcare professionals and, ultimately, children with cancer everywhere.

Plain English
This study looked at a training program for doctors in Guatemala, focusing on childhood cancer treatment. Since launching in 2003, 40 doctors from 10 Latin American countries have completed the program, and 39 of them, or 98%, are now working as pediatric cancer specialists. This matters because it addresses the critical shortage of such specialists in the region, improving care for children with cancer. Who this helps: Patients with childhood cancer and their families in Latin America.

Plain English
This study examined how parents and healthcare providers communicate during the cancer diagnosis process for children in Guatemala. Researchers found that only 15% of fathers and 5% of mothers had education beyond primary school, and during conversations, providers spoke much more than parents—68% of the time during psychoeducation and 85% during diagnosis discussions. The results showed that supportive communication from providers encouraged parents to engage more actively, which is crucial for effective care and decision-making. Who this helps: This helps parents of children with cancer and healthcare providers.

Plain English
This study compared two medical evacuation systems created to help Ukrainian patients affected by the war, focusing on their effectiveness in getting patients to safety. The European Union's ERCC system evacuated 1,385 patients, mostly adults with trauma, while SAFER Ukraine helped 550 patients, mostly children with cancer or blood disorders. Evacuations took about six days for SAFER Ukraine and seven days for ERCC, showing SAFER had a faster process. Understanding which system worked better can help create more efficient medical responses in future conflicts. Who this helps: This benefits patients, especially children with serious health conditions, and the healthcare providers supporting them.

Plain English
This study focused on a rare type of cancer in children called adrenocortical carcinoma (ACT). Researchers found that early diagnosis is crucial for curing this cancer, but it becomes much harder to treat if it's advanced or linked to certain genetic mutations. They also noted that new treatment approaches, including advanced therapies targeting blood vessel growth and immune system modulation, show potential for improving outcomes. Who this helps: This research benefits pediatric cancer patients and their doctors by informing better treatment options and early detection strategies.

Plain English
This study examined how caregivers of children with newly diagnosed cancer understand their child's illness at a pediatric cancer center in Guatemala. Researchers recorded conversations between families and healthcare providers and found that while all key aspects of understanding the illness were discussed, caregivers rarely talked about the biological basis of the disease. The findings highlight the importance of acknowledging both medical and personal beliefs about illness to improve communication and care for pediatric cancer patients. Who this helps: This benefits patients and their families by improving the support they receive from healthcare teams.

Plain English
This study looked at how doctors in low- and middle-income countries decide on treatments for children diagnosed with advanced cancer. Eleven pediatric oncologists shared their experiences, revealing that many factors, such as community resources and hospital policies, influence their decisions. They found that all participants agreed there are situations where doctors consider offering non-curative treatments right at diagnosis, even though definitions of "poor prognosis" vary widely. Who this helps: This research aids pediatric oncologists and healthcare systems in improving decision-making processes for treating children with advanced cancer.

Plain English
Researchers created a new tool called PANORAMA to assess how well hospitals provide care for children with brain tumors. After working with experts from various fields, they identified 14 key areas of care, like hospital organization and treatment options, and tested the tool in 13 hospitals across 12 countries. This tool will help identify areas needing improvement, ensuring children receive better treatment and outcomes. Who this helps: This helps pediatric patients with brain tumors and their healthcare providers.

Plain English
This paper looks at how the Children's Oncology Group studies rare childhood tumors, such as adrenocortical carcinoma and retinoblastoma. It highlights the need for global collaboration and inclusiveness in research to overcome the challenges posed by these uncommon cancers, which can lead to better care and treatment for affected children. Importantly, these efforts work towards improving outcomes for very rare tumors that often lack adequate research. Who this helps: This benefits children with rare tumors and their doctors.